Category | Normal UA group (n = 26) | Hyperuricemic group (n = 38) | P |
---|---|---|---|
Age, means ± SD, year | 54.96 ± 2.20 | 52.90 ± 16.54 | 0.553 |
Male, n (%) | 22 (84.6) | 33(86.8) | 0.801 |
BMI, means ± SD, Kg/m2 | 24.11 ± 3.12 | 24.50 ± 3.54 | 0.649 |
Gout induction time, means ± SD, day | 2.50 ± 1.39 | 2.74 ± 0.37 | 0.641 |
Admission uric acid, means ± SD, μmol/L | 319.67 ± 62.23 | 546.45 ± 78.91 | < 0.001 |
Gout attack uric acid, means ± SD, μmol/L | 231.08 ± 97.91 | 442.96 ± 110.45 | < 0.001 |
Gout relieves uric acid, means ± SD, μmol/L | 277.28 ± 48.01 | 418.96 ± 80.08 | < 0.001 |
Uric acid drop ratio (%) | 42.12 ± 19.52 | 22.65 ± 10.24 | < 0.001 |
Gout duration, means ± SD, day | 4.46 ± 1.94 | 5.55 ± 2.74 | 0.085 |
Inflammatory markers during gout attack, means ± SD | |||
 WBC (109/L) | 12.17 ± 4.42 | 10.23 ± 2.18 | 0.047 |
 CRP (mg/dl) | 138.36 ± 86.58 | 85.83 ± 47.15 | 0.008 |
 ESR (mm/h) | 74.65 ± 38.12 | 65.67 ± 32.20 | 0.313 |
Inflammatory markers in gout remission, means ± SD | |||
 WBC (109/L) | 9.27 ± 2.67 | 8.07 ± 2.53 | 0.075 |
 CRP (mg/dl) | 54.73 ± 53.26 | 45.16 ± 37.27 | 0.400 |
 ESR (mm/h) | 57.67 ± 21.25 | 49.97 ± 23.09 | 0.181 |
Fever, n (%) | 12 (46.2) | 10 (26.3) | 0.101 |
Hypertension, n (%) | 12 (46.2) | 18 (47.4) | 0.924 |
Hyperlipidemia, n (%) | 16 (61.5) | 23 (60.5) | 0.935 |
Diabetes, n (%) | 3 (11.5) | 15 (39.5) | 0.015 |
Coronary heart disease, n (%) | 10 (38.5) | 12 (31.6) | 0.569 |
Renal insufficiency, n (%) | 2 (7.7) | 6 (15.8) | 0.336 |
Smoking, n (%) | 8 (30.8) | 15 (39.5) | 0.476 |
Tophi, n (%) | 2 (7.7) | 20 (52.6) | < 0.001 |
Diuretics, n (%) | 4 (15.4) | 19 (50.0) | 0.005 |
Drinking, n (%) | 10 (38.5) | 9 (23.7) | 0.204 |
Aspirin, n (%) | 5 (19.2) | 9 (23.7) | 0.672 |
Affected joints, n (%) | 0.003 | ||
 Single joint | 22 (84.6) | 18 (47.4) |  |
 Multi-joint | 4 (15.4) | 20 (52.6) |  |